AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2019
Apr 30, 2019
30786_dirs_2019-04-30_234464d9-08aa-4cc8-b2ea-a264b6f267a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-04-29
Reporting Person: Last Andrew J. (EVP, Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-04-29 | Restricted Stock Units | $0 | A | 5000 | Acquired | Bio-Rad A Common Stock (5000) | Direct | |
| 2019-04-29 | Non-Qualified Stock Option (right to buy) | $299.24 | A | 5000 | Acquired | 2029-04-29 | Bio-Rad A Common Stock (5000) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F2: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
F3: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13